Dr. Xu is a biostatistician and Clinician Scientist at the Princess Margaret Cancer Center, and an Associate Professor in Biostatistics at the University of Toronto's Dalla Lana School of Public Health. As Principal-Investigator or co-Investigator, he has been involved in study design, data administration, statistical modeling development and data analysis on different clinical research and human genetic studies. He has published over 250 peer-reviewed papers in the field of statistics, bioinformatics, medical science and human genetics.

Dr. Xu’s research interests focus on clinical trial design and methodology, biostatistics and bioinformatics methodology, statistical genetics, and cancer clinical and translational research.
A chemical probe of CARM1 alters epigenetic plasticity against breast cancer cell invasion.
Elife. 2019 Oct 28;8:
Cai XC, Zhang T, Kim EJ, Jiang M, Wang K, Wang J, Chen S, Zhang N, Wu H, Li F, Dela Seña CC, Zeng H, Vivcharuk V, Niu X, Zheng W, Lee JP, Chen Y, Barsyte D, Szewczyk M, Hajian T, Ibáñez G, Dong A, Dombrovski L, Zhang Z, Deng H, Min J, Arrowsmith CH,...
Real-world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non-small cell lung cancer.
Cancer Med. 2019 Oct 24;:
Jiang SX, Walton RN, Hueniken K, Baek J, McCartney A, Labbé C, Smith E, Chan SWS, Chen R, Brown C, Patel D, Liang M, Eng L, Sacher A, Bradbury P, Leighl NB, Shepherd FA, Xu W, Liu G, Hurry M, O'Kane GM
Evaluation of Older Age and Frailty as Factors Associated With Depression and Postoperative Decision Regret in Patients Undergoing Major Head and Neck Surgery.
JAMA Otolaryngol Head Neck Surg. 2019 Oct 17;:
Thomas CM, Sklar MC, Su J, Xu W, de Almeida JR, Gullane P, Gilbert R, Brown D, Irish J, Alibhai SMH, Goldstein DP
The Prevalence and Determinants of Return to Work in Nasopharyngeal Carcinoma Survivors.
Int J Radiat Oncol Biol Phys. 2019 Sep 27;:
So N, McDowell LJ, Lu L, Xu W, Rock K, Waldron J, Bernstein LJ, Chan HB, Huang SH, Giuliani M, Hope A, O'Sullivan B, Bratman SV, Cho J, Kim J, Jang R, Bayley A, Ringash J
Treatment outcomes in oropharynx cancer patients who did not complete planned curative radiotherapy.
Oral Oncol. 2019 Oct;97:124-130
Alfaraj F, Craig T, Huang SH, O'Sullivan B, Su J, Bayley A, Bratman S, Cho J, Giuliani M, Kim J, Ringash J, Waldron J, Hansen A, de Almeida J, Perez-Ordonez B, Weinreb I, Tong L, Xu W, Hope A
Clinical Outcomes of Surgically Unresectable Endometrial Cancers.
Am J Clin Oncol. 2019 Oct;42(10):777-782
Conway JL, Lukovic J, Ferguson SE, Zhang J, Xu W, Dhani N, Croke J, Fyles A, Milosevic M, Rink A, Rouzbahman M, Han K
Postoperative wound infections, neutrophil-to-lymphocyte ratio, and cancer recurrence in patients with oral cavity cancer undergoing surgical resection.
Oral Oncol. 2019 Oct;97:23-30
de Almeida JR, Yao CMKL, Ziai H, Staibano P, Huang SH, Hosni A, Hope A, Bratman SV, Monteiro E, Gilbert RW, Brown DH, Gullane PJ, Irish JC, Su J, Xu W, Goldstein DP
Frailty as a predictor of outcomes in patients undergoing head and neck cancer surgery.
Laryngoscope. 2019 Aug 16;:
Goldstein DP, Sklar MC, de Almeida JR, Gilbert R, Gullane P, Irish J, Brown D, Higgins K, Enepekides D, Xu W, Su J, Alibhai SMH
Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience.
Oncologist. 2019 Aug 13;:
Albaba H, Barnes TA, Veitch Z, Brown MC, Shakik S, Su S, Naik H, Wang T, Liang M, Perez-Cosio A, Eng L, Mittmann N, Xu W, Howell D, Liu G
Comprehensive Characterization of a Canadian Cohort of von Hippel-Lindau Disease Patients.
Clin Genet. 2019 Aug 01;:
Salama Y, Albanyan S, Szybowska M, Bullivant G, Gallinger B, Giles RH, Asa S, Badduke C, Chiorean A, Druker H, Ezzat S, Hannah-Shmouni F, Hernandez KG, Inglese C, Jani P, Kaur Y, Krema H, Krimus L, Laperriere N, Lichner Z, Mete O, Sit M, Zadeh G,...

Pages

Clinician Scientist, Princess Margaret Cancer Centre

Principal Biostatistician, Princess Margaret Cancer Center, UHN
Associate Professor, Dalla Lana School of Public Health, University of Toronto